N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer

Endocrine-Related Cancer

Volumn 17, Issue 2, 2010, Pages 469-479

  Jennbacken, Karin ^a   Tešan, Tajana ^a   Wang, Wanzhong ^a   Gustavsson, Heléne ^a   Damber, Jan Erik ^a   Welén, Karin ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; NERVE CELL ADHESION MOLECULE;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CASTRATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MESENCHYME CELL; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PROSTATE CANCER; PROSTATE TUMOR; PROTEIN EXPRESSION; TUMOR BIOPSY; TUMOR XENOGRAFT;

ANDROGENS; ANIMALS; ANTIGENS, CD; CADHERINS; CARCINOMA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; ORCHIECTOMY; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRANSPLANTATION, HETEROLOGOUS; TREATMENT FAILURE; UP-REGULATION;

EID: 77953576511     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-10-0015     Document Type: Article

References (45)

1. Anderson JB 1999 Early versus deferred hormone therapy. European Urology 36 (Supplement 2) 9-13.
2. Augustine CK, Yoshimoto Y, Gupta M, Zipfel PA, Selim MA, Febbo P, Pendergast AM, Peters WP & Tyler DS 2008 Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment. Cancer Research 68 3777-3784.
3. Beasley GM, McMahon N, Sanders G, Augustine CK, Selim MA, Peterson B, Norris R, Peters WP, Ross MI & Tyler DS 2009 A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma. Cancer 115 4766-4774.
4. Bussemakers MJ, Van Bokhoven A, Tomita K, Jansen CF & Schalken JA 2000 Complex cadherin expression in human prostate cancer cells. International Journal of Cancer 85 446-450. (Pubitemid 30030421)
5. Chambers AF, Groom AC & MacDonald IC 2002 Dissemination and growth of cancer cells in metastatic sites. Nature Reviews. Cancer 2 563-572.
6. Chu YS, Thomas WA, Eder O, Pincet F, Perez E, Thiery JP & Dufour S 2004 Force measurements in E-cadherin-mediated cell doublets reveal rapid adhesion strengthened by actin cytoskeleton remodeling through Rac and Cdc42. Journal of Cell Biology 167 1183-1194.
7. Cinar B, Koeneman KS, Edlund M, Prins GS, Zhau HE & Chung LW 2001 Androgen receptor mediates the reduced tumor growth, enhanced androgen responsiveness, and selected target gene transactivation in a human prostate cancer cell line. Cancer Research 61 7310-7317. (Pubitemid 32946530)
8. Damber JE & Aus G 2008 Prostate cancer. Lancet 371 1710-1721.
9. Derycke LD & Bracke ME 2004 N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. International Journal of Developmental Biology 48 463-476.
10. Derycke L, De Wever O, Stove V, Vanhoecke B, Delanghe J, Depypere H & Bracke M 2006a Soluble N-cadherin in human biological fluids. International Journal of Cancer 119 2895-2900.
11. Derycke L, Morbidelli L, Ziche M, De Wever O, BrackeM& Van Aken E 2006b Soluble N-cadherin fragment promotes angiogenesis. Clinical and Experimental Metastasis 23 187-201.
12. Giehl K & Menke A 2008 Microenvironmental regulation of E-cadherin-mediated adherens junctions. Frontiers in Bioscience 13 3975-3985.
13. Gravdal K, Halvorsen OJ, Haukaas SA & Akslen LA 2007 A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clinical Cancer Research 13 7003-7011.
14. Gregory CW, He B, Johnson RT, Ford OH, Mohler JL, French FS & Wilson EM 2001 A mechanism for androgen receptor-mediated prostate cancer recurrence after androgen deprivation therapy. Cancer Research 61 4315-4319. (Pubitemid 32685750)
15. Gustavsson H, Welen K & Damber JE 2005 Transition of an androgen-dependent human prostate cancer cell line into an androgen-independent subline is associated with increased angiogenesis. Prostate 62 364-373.
16. Hara T, Miyazaki H, Lee A, Tran CP & Reiter RE 2008 Androgen receptor and invasion in prostate cancer. Cancer Research 68 1128-1135.
17. Hatta K, Takagi S, Fujisawa H & Takeichi M 1987 Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos. Developmental Biology 120 215-227.
18. Hazan RB, Kang L, Whooley BP & Borgen PI 1997 N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhesion and Communication 4 399-411. (Pubitemid 27248390)
19. Hazan RB, Phillips GR, Qiao RF, Norton L & Aaronson SA 2000 Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. Journal of Cell Biology 148 779-790.
20. Jaggi M, Nazemi T, Abrahams NA, Baker JJ, Galich A, Smith LM & Balaji KC 2006 N-cadherin switching occurs in high Gleason grade prostate cancer. Prostate 66 193-199.
21. Jennbacken K, Gustavsson H, Welen K, Vallbo C & Damber JE 2006 Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity. Prostate 66 1631-1640.
22. Jennbacken K, Gustavsson H, Tesan T, Horn M, Vallbo C, Welen K & Damber JE 2009 The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: an effect influenced by testosterone. Prostate 69 1164-1175.
23. Kleeberger W, Bova GS, Nielsen ME, Herawi M, Chuang AY, Epstein JI & Berman DM 2007 Roles for the stem cell associated intermediate filament Nestin in prostate cancer migration and metastasis. Cancer Research 67 9199-9206.
24. Lee EC & Tenniswood MP 2004 Emergence of metastatic hormone-refractory disease in prostate cancer after anti-androgen therapy. Journal of Cellular Biochemistry 91 662-670.
25. Li G, Satyamoorthy K & Herlyn M 2001 N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Research 61 3819-3825. (Pubitemid 32694999)
26. Li J, Wang E, Rinaldo F & Datta K 2005 Upregulation of VEGF-C by androgen depletion: the involvement of IGF-IR-FOXO pathway. Oncogene 24 5510-5520.
27. Linja MJ, Savinainen KJ, Saramaki OR, Tammela TL, Vessella RL & Visakorpi T 2001 Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Research 61 3550-3555. (Pubitemid 32694958)
28. Maeda M, Johnson KR & Wheelock MJ 2005 Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. Journal of Cell Science 118 873-887.
29. Marcelli M, Ittmann M, Mariani S, Sutherland R, Nigam R, Murthy L, Zhao Y, DiConcini D, Puxeddu E, Esen A et al. 2000 Androgen receptor mutations in prostate cancer. Cancer Research 60 944-949.
30. Monks DA & Watson NV 2001 N-cadherin expression in motoneurons is directly regulated by androgens: a genetic mosaic analysis in rats. Brain Research 895 73-79.
31. Niu Y, Altuwaijri S, Lai KP, Wu CT, Ricke WA, Messing EM, Yao J, Yeh S & Chang C 2008 Androgen receptor is a tumor suppressor and proliferator in prostate cancer. PNAS 105 12182-12187.
32. Perotti A, Sessa C, Mancuso A, Noberasco C, Cresta S, Locatelli A, Carcangiu ML, Passera K, Braghetti A, Scaramuzza D et al. 2009 Clinical and pharmacological phase I evaluation of ExherinTM (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours. Annals of Oncology 20 741-745.
33. Rinaldo F, Li J, Wang E, Muders M & Datta K 2007 RalA regulates vascular endothelial growth factor-C (VEGF-C) synthesis in prostate cancer cells during androgen ablation. Oncogene 26 1731-1738.
34. Salomon D, Ayalon O, Patel-King R, Hynes RO & Geiger B 1992 Extrajunctional distribution of N-cadherin in cultured human endothelial cells. Journal of Cell Science 102 7-17.
35. Sandig M, Voura EB, Kalnins VI & Siu CH 1997 Role of cadherins in the transendothelial migration of melanoma cells in culture. Cell Motility and the Cytoskeleton 38 351-364.
36. Shintani Y, Fukumoto Y, Chaika N, Grandgenett PM, Hollingsworth MA, Wheelock MJ & Johnson KR 2008 ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression. International Journal of Cancer 122 71-77.
37. Suyama K, Shapiro I, Guttman M & Hazan RB 2002 A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2 301-314.
38. Takayama K, Kaneshiro K, Tsutsumi S, Horie-Inoue K, Ikeda K, Urano T, Ijichi N, Ouchi Y, Shirahige K, Aburatani H et al. 2007 Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis. Oncogene 26 4453-4463.
39. Terry S, Ploussard G, Allory Y, Nicolaiew N, Boissiere-Michot F, Maille P, Kheuang L, Coppolani E, Ali A, Bibeau F et al. 2009 Increased expression of class III beta-tubulin in castration-resistant human prostate cancer. British Journal of Cancer 101 951-956.
40. Tesan T, Gustavsson H, Welen K & Damber JE 2008 Differential expression of angiopoietin-2 and vascular endothelial growth factor in androgen-independent prostate cancer models. BJU International 102 1034-1039.
41. Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ & Schalken JA 2000 Cadherin switching in human prostate cancer progression. Cancer Research 60 3650-3654. (Pubitemid 30482189)
42. Tran NL, Nagle RB, Cress AE & Heimark RL 1999 N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion with stromal cells. American Journal of Pathology 155 787-798.
43. Tran NL, Adams DG, Vaillancourt RR & Heimark RL 2002 Signal transduction from N-cadherin increases Bcl-2. Regulation of the phosphatidylinositol 3-kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization. Journal of Biological Chemistry 277 32905-32914.
44. Wikstrom P, Westin P, Stattin P, Damber JE & Bergh A 1999 Early castration-induced upregulation of transforming growth factor beta1 and its receptors is associated with tumor cell apoptosis and a major decline in serum prostate-specific antigen in prostate cancer patients. Prostate 38 268-277. (Pubitemid 29119792)
45. Xie D, Gore C, Liu J, Pong RC, Mason R, Hao G, Long M, Kabbani W, Yu L, Zhang H et al. 2010 Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis. PNAS 107 2485-2490.